Jiali Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiali Liu has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Hui-Ying Qin
Sun Yat-Sen University Cancer Center, Guangzhou, China
1 shared publication Huiyin Qin
Department of Nursing, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
1 shared publicationJianhua Zhan
Department of Clinical Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
1 shared publicationJing Zheng
School of Nursing Guangdong Pharmaceutical University Guangzhou China
1 shared publicationJuan Yu
Department of Medical oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
1 shared publication- Juan Yu
Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Sun Yat‐Sen University Cancer Center Guangzhou P.R. China
1 shared publication
Latest Publications
- 4 May 2023
- Published by Wiley in Journal of Advanced Nursing
- Vol. 79 (9) , 3549-3558
The relationships among symptom experience, family support, health literacy, and fear of progression in advanced lung cancer patients
Aims: Fear of progression of cancer patients can affect their psychological well‐being, while research on fear of progression of advanced lung cancer patients is limited. This study aimed to describe fear of progression among advanced lung cancer patients and explore the relationships among symptom experience, family support, health literacy, and fear of progression.Design: This study was a cross‐sectional study.Methods: Convenience sampling was used to select advanced lung cancer patients from September 2021 to January 2022. The Chinese version of the Fear of Progression Questionnaire‐Short Form, Lung Cancer Module of the MD Anderson Symptom Inventory, Family Support Questionnaire, and Health Literacy Scale for Patients with Chronic Disease were used to collect data. The structural equation modelling was used to analyse the relationships among symptom experience, family support, health literacy, and fear of progression.Results: Of 220 patients, 31.8% had dysfunctional fear of progression. Better symptom experience, higher family support, and higher health literacy were correlated directly with lower fear of progression. Higher health literacy was associated indirectly with lower fear of progression through the mediation of better symptom experience.Conclusion: Fear of progression among advanced lung cancer patients needs attention. Strengthening symptom management, building a strong system of family support, and improving patients' health literacy may be effective strategies to reduce fear of progression.Impact: The research aimed to increase our understanding of the relationships among symptom experience, family support, health literacy, and fear of progression. Fear of progression screening should be integrated into the healthcare trajectory of advanced lung cancer patients. The results emphasize that improving symptom management, family support, and health literacy is important to alleviate fear of progression. Further interventions are warranted to relieve fear of progression for advanced lung cancer patients.Patient or public contribution: No public or patient involvement.
- 4 May 2023
- Published by Wiley in Journal of Advanced Nursing
- Vol. 79 (9) , 3549-3558
The relationships among symptom experience, family support, health literacy, and fear of progression in advanced lung cancer patients
Aims: Fear of progression of cancer patients can affect their psychological well‐being, while research on fear of progression of advanced lung cancer patients is limited. This study aimed to describe fear of progression among advanced lung cancer patients and explore the relationships among symptom experience, family support, health literacy, and fear of progression.Design: This study was a cross‐sectional study.Methods: Convenience sampling was used to select advanced lung cancer patients from September 2021 to January 2022. The Chinese version of the Fear of Progression Questionnaire‐Short Form, Lung Cancer Module of the MD Anderson Symptom Inventory, Family Support Questionnaire, and Health Literacy Scale for Patients with Chronic Disease were used to collect data. The structural equation modelling was used to analyse the relationships among symptom experience, family support, health literacy, and fear of progression.Results: Of 220 patients, 31.8% had dysfunctional fear of progression. Better symptom experience, higher family support, and higher health literacy were correlated directly with lower fear of progression. Higher health literacy was associated indirectly with lower fear of progression through the mediation of better symptom experience.Conclusion: Fear of progression among advanced lung cancer patients needs attention. Strengthening symptom management, building a strong system of family support, and improving patients' health literacy may be effective strategies to reduce fear of progression.Impact: The research aimed to increase our understanding of the relationships among symptom experience, family support, health literacy, and fear of progression. Fear of progression screening should be integrated into the healthcare trajectory of advanced lung cancer patients. The results emphasize that improving symptom management, family support, and health literacy is important to alleviate fear of progression. Further interventions are warranted to relieve fear of progression for advanced lung cancer patients.Patient or public contribution: No public or patient involvement.
- Open Access
Prognostic effects of health-related quality of life at baseline and early change in health-related quality of life on response to treatment and survival in patients with advanced lung cancer: a prospective observational study in China
Objectives To investigate the relationship among baseline health-related quality of life (HRQoL), early changes in HRQoL from baseline to completion of the first cycle of chemotherapy, and prognosis in patients with advanced lung cancer. Design This was a prospective, observational study. Setting The study was conducted in a national cancer centre in South China. Participants A total of 243 patients with chemo-naïve with advanced lung cancer were enrolled. Intervention None. Primary and secondary outcome measures The Functional Assessment of Cancer Therapy-Lung was used to assess HRQoL at baseline and at the end of the first cycle of chemotherapy. The Trial Outcome Index (TOI) and Lung Cancer Scale (LCS) were calculated as predictive indicators. Response to treatment was evaluated as per the Response Evaluation Criteria in Solid Tumors (RECIST) V.1.1. Survival data were gathered from follow-up to September 2019. Results Patients with 5-point or greater decreases in TOI (65% vs 48%, adjusted risk ratio (aRR)=2.19, 95% CI 1.09 to 4.41) or 2-point or greater decreases in LCS (72% vs 48%, aRR=3.29, 95% CI 1.50 to 7.22) from baseline to completion of the first cycle of chemotherapy were more likely to show stable or progressive disease than those whose HRQoL had improved. Baseline TOI ≤54 (80.0% vs 69.9%, adjusted hazard risk (aHR)=1.36, 95% CI 1.01 to 1.84) and LCS ≤21 (77.6% vs 72.5%, aHR=1.36, 95% CI 1.01 to 1.83) were associated with higher risk for death compared with TOI>54 and LCS>21. Area under the curve analysis indicated that early changes in LCS and baseline LCS scores could better predict response to treatment and overall survival than the corresponding TOI values. Conclusions Higher pretreatment HRQoL scores could predict longer survival, while declining HRQoL values could predict unfavourable treatment outcome among patients with advanced lung cancer. The use of the LCS is recommended for the routine collection of patient-reported HRQoL. Trial registration number NCT01914120.
Open AccessPrognostic effects of health-related quality of life at baseline and early change in health-related quality of life on response to treatment and survival in patients with advanced lung cancer: a prospective observational study in China
Objectives To investigate the relationship among baseline health-related quality of life (HRQoL), early changes in HRQoL from baseline to completion of the first cycle of chemotherapy, and prognosis in patients with advanced lung cancer. Design This was a prospective, observational study. Setting The study was conducted in a national cancer centre in South China. Participants A total of 243 patients with chemo-naïve with advanced lung cancer were enrolled. Intervention None. Primary and secondary outcome measures The Functional Assessment of Cancer Therapy-Lung was used to assess HRQoL at baseline and at the end of the first cycle of chemotherapy. The Trial Outcome Index (TOI) and Lung Cancer Scale (LCS) were calculated as predictive indicators. Response to treatment was evaluated as per the Response Evaluation Criteria in Solid Tumors (RECIST) V.1.1. Survival data were gathered from follow-up to September 2019. Results Patients with 5-point or greater decreases in TOI (65% vs 48%, adjusted risk ratio (aRR)=2.19, 95% CI 1.09 to 4.41) or 2-point or greater decreases in LCS (72% vs 48%, aRR=3.29, 95% CI 1.50 to 7.22) from baseline to completion of the first cycle of chemotherapy were more likely to show stable or progressive disease than those whose HRQoL had improved. Baseline TOI ≤54 (80.0% vs 69.9%, adjusted hazard risk (aHR)=1.36, 95% CI 1.01 to 1.84) and LCS ≤21 (77.6% vs 72.5%, aHR=1.36, 95% CI 1.01 to 1.83) were associated with higher risk for death compared with TOI>54 and LCS>21. Area under the curve analysis indicated that early changes in LCS and baseline LCS scores could better predict response to treatment and overall survival than the corresponding TOI values. Conclusions Higher pretreatment HRQoL scores could predict longer survival, while declining HRQoL values could predict unfavourable treatment outcome among patients with advanced lung cancer. The use of the LCS is recommended for the routine collection of patient-reported HRQoL. Trial registration number NCT01914120.
- Open Access
- 4 August 2021
- Published by Wiley in Journal of Nursing Management
- Vol. 29 (8) , 2630-2638
Changes over 10 years in the nursing workforce in Guangdong province, China: Three‐wave multisite surveys
Aims The study aimed to describe the changes in the nursing workforce in 2008–2018 in Guangdong province, China. Background A strong nursing workforce is important in the development of the health care system in China. However, whether the nursing workforce in China has improved is underexplored. Methods Three waves of surveys were conducted in hospitals in Guangdong province, China, in 2008, 2014 and 2018. Findings The proportion of less experienced nurses and nurses holding a bachelor's degree has increased. The hospital nurse-to-patient ratio did not change significantly. The work environment deteriorated from 2008 to 2014 and improved from 2014 to 2018. Nurse-perceived staffing adequacy and nurses participating in hospital administration were scored lowest. The nurse–physician relations declined from 2008 to 2018. Nurse satisfaction, retention and quality of care improved, while reduced personal accomplishment deteriorated. Conclusion The nursing workforce in Guangdong province, China, is young and highly educated. Nurse outcomes and quality of care have made progress from 2008 to 2018. Nurse staffing and burnout remain matters of concern. Implications for nursing management Strategies addressing nursing workforce issues in China include dealing with the nursing shortage, establishing pathways for nurses' participation in decision-making, increasing nurses' income and welfare, promoting recognition of nurses and improving the quality of care.
- 4 August 2021
- Published by Wiley in Journal of Nursing Management
- Vol. 29 (8) , 2630-2638
Open AccessChanges over 10 years in the nursing workforce in Guangdong province, China: Three‐wave multisite surveys
Aims The study aimed to describe the changes in the nursing workforce in 2008–2018 in Guangdong province, China. Background A strong nursing workforce is important in the development of the health care system in China. However, whether the nursing workforce in China has improved is underexplored. Methods Three waves of surveys were conducted in hospitals in Guangdong province, China, in 2008, 2014 and 2018. Findings The proportion of less experienced nurses and nurses holding a bachelor's degree has increased. The hospital nurse-to-patient ratio did not change significantly. The work environment deteriorated from 2008 to 2014 and improved from 2014 to 2018. Nurse-perceived staffing adequacy and nurses participating in hospital administration were scored lowest. The nurse–physician relations declined from 2008 to 2018. Nurse satisfaction, retention and quality of care improved, while reduced personal accomplishment deteriorated. Conclusion The nursing workforce in Guangdong province, China, is young and highly educated. Nurse outcomes and quality of care have made progress from 2008 to 2018. Nurse staffing and burnout remain matters of concern. Implications for nursing management Strategies addressing nursing workforce issues in China include dealing with the nursing shortage, establishing pathways for nurses' participation in decision-making, increasing nurses' income and welfare, promoting recognition of nurses and improving the quality of care.